Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 148
Genomics 73
Biopharmaceuticals 72
Immune Disorders Drugs 71
Biotechnology 50
Musculoskeletal Disorders Drugs 42
Oncology Drugs 40
Pharmaceuticals 40
Drug Discovery 37
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 26
Infusions and Injectables 25
Allergy and Immunology 23
Cardiovascular Drugs 23
Optical Disorders Drugs 21
Clinical Trials 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Optical 13
Infectious Diseases Drugs 12
Immunosuppressive Drugs 12
Healthcare Services 11
Analgesics 11
Hematology 11
Gastrointestinal Drugs 11
Drug Delivery 10
Pharmaceutical Manufacturing 10
Lymphoma Drugs 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Drugs by Therapeutic Area 8
Leukemia Drugs 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Medical Devices 6
Enzymes 5
Neurology Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Surgical Devices 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Palliative Care 1
Pediatrics 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

848 Results (Page 7 of 43)
- Relevance
  Sort by

Central Nervous System Biomarkers - Global Strategic Business Report

 Report
March 2026
376 Pages
Global

From

€5258EUR$5,850USD£4,565GBP

Fertility Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4036EUR$4,490USD£3,503GBP

Psychiatric Digital Biomarkers Market - Global Strategic Business Report

 Report
March 2026
386 Pages
Global

From

€5258EUR$5,850USD£4,565GBP

Pediatric Epilepsy Therapeutics - Global Strategic Business Report

 Report
March 2026
184 Pages
Global

From

€5258EUR$5,850USD£4,565GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
March 2026
385 Pages
Global

From

€5258EUR$5,850USD£4,565GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Skeletal Dysplasia Market - Global Strategic Business Report

 Report
March 2026
378 Pages
Global

From

€5258EUR$5,850USD£4,565GBP

Alzheimer's Disease: 68-Market Analysis and Sales Forecast - Update

 Report
August 2025
19 Pages
Global

From

€16175EUR$17,995USD£14,041GBP

Alzheimer's Disease: Eight-Market Drug Forecast and Market Analysis - Update

 Report
August 2025
160 Pages
Global

From

€16175EUR$17,995USD£14,041GBP

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

 Report
April 2025
120 Pages
Global

From

€5348EUR$5,950USD£4,643GBP

Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030

 Report
July 2024
150 Pages
Global

From

€5348EUR$5,950USD£4,643GBP

Bone Marrow Transplant Rejection Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
93 Pages
Global

From

€3500EUR$4,171USD£3,145GBP

Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032

 Report
April 2023
164 Pages
Global

From

€8539EUR$9,500USD£7,412GBP

Plaque Psoriasis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
96 Pages
Global

From

€3500EUR$4,171USD£3,145GBP

Alzheimer's Disease Treatment Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
November 2024
89 Pages
Global

From

€3500EUR$4,171USD£3,145GBP

Non-Opioid Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
197 Pages
Global

From

€3187EUR$3,545USD£2,766GBP

€3541EUR$3,939USD£3,073GBP

Irritable Bowel Syndrome (IBS) Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4036EUR$4,490USD£3,503GBP

Intestinal Pseudo-Obstruction Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4036EUR$4,490USD£3,503GBP

Alzheimer's Disease Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4036EUR$4,490USD£3,503GBP

Acute Ischemic Stroke Therapeutics Market 2026-2030

 Report
January 2026
291 Pages
Global

From

€2247EUR$2,500USD£1,951GBP

Neuroprotection Therapeutics - Global Strategic Business Report

 Report
March 2026
194 Pages
Global

From

€5258EUR$5,850USD£4,565GBP

848 Results (Page 7 of 43)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.